Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Alterity Therapeutics ( (AU:ATH) ).
Alterity Therapeutics Limited has released its Corporate Governance Statement for the financial year ending 2025, detailing its adherence to the ASX Corporate Governance Council’s principles. The company has implemented a comprehensive Corporate Governance Plan, including a Board Charter that defines the roles and responsibilities of its board members and management. This announcement underscores Alterity’s commitment to transparency and accountability, potentially strengthening its position in the industry and enhancing stakeholder confidence.
More about Alterity Therapeutics
Alterity Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic products for neurodegenerative diseases. The company is committed to advancing treatments that address unmet medical needs in this specialized market.
YTD Price Performance: 30.0%
Average Trading Volume: 13,877,320
Technical Sentiment Signal: Sell
Current Market Cap: A$110.5M
Learn more about ATH stock on TipRanks’ Stock Analysis page.